| scholarly article | Q13442814 |
| P2093 | author name string | Anand Mohan | |
| David Perera | |||
| Mary Jane Cardosa | |||
| Yuwana Podin | |||
| Tom Solomon | |||
| Phaik Hooi Tio | |||
| Chae Hee Chieng | |||
| Daniella Clear | |||
| Mong How Ooi | |||
| See Chang Wong | |||
| Sylvia del Sel | |||
| P2860 | cites work | Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses | Q24791827 |
| Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: improved primers for the specific detection of human enterovirus 71 by RT PCR | Q24800087 | ||
| Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore | Q30233446 | ||
| An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. | Q33875086 | ||
| Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes | Q34215993 | ||
| Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. | Q35913835 | ||
| Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia | Q39606586 | ||
| Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. | Q40458463 | ||
| Heart rate variability monitoring in the detection of central nervous system complications in children with enterovirus infection. | Q40469368 | ||
| Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. | Q40628631 | ||
| Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak | Q40632168 | ||
| Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. | Q43523822 | ||
| Outbreak of severe neurologic involvement associated with Enterovirus 71 infection | Q44881432 | ||
| Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection | Q48284752 | ||
| Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis | Q48464853 | ||
| Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. | Q51642559 | ||
| The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management | Q57105763 | ||
| Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease | Q73198212 | ||
| Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course | Q77734381 | ||
| Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002 | Q79892365 | ||
| Critical management in patients with severe enterovirus 71 infection | Q83867164 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | mouth disease | Q2508462 |
| P304 | page(s) | 3 | |
| P577 | publication date | 2009-01-19 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak | |
| P478 | volume | 9 |
| Q64239858 | A case report of a teenager with severe hand, foot, and mouth disease with brainstem encephalitis caused by enterovirus 71 |
| Q38004910 | A case-control study of risk factors for severe hand-foot-mouth disease among children in Ningbo, China, 2010-2011. |
| Q45294358 | A case-control study of risk factors for severe hand-foot-mouth disease in Yuxi, China, 2010-2012. |
| Q28072005 | A literature review and case report of hand, foot and mouth disease in an immunocompetent adult |
| Q34002056 | A neonate with hand, foot, and mouth disease complicated with brainstem encephalitis and pulmonary edema:A complete recovery. |
| Q36277352 | A nine-month-old girl with respiratory failure and rhomboencephalitis |
| Q35826494 | A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection |
| Q59357875 | Acute Flaccid Paralysis and Enteroviral Infections |
| Q36965378 | Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. |
| Q37303819 | Children of rural-to-urban migrant workers in China are at a higher risk of contracting severe hand, foot and mouth disease and EV71 infection: a hospital-based study |
| Q36151046 | Circadian rhythm disruption was observed in hand, foot, and mouth disease patients |
| Q47559207 | Clinical characteristics of hand, foot and mouth disease in Daklak Province, Vietnam and associated factors of severe cases |
| Q40301917 | Clinical features and management outcomes of severe hand, foot and mouth disease |
| Q34144978 | Clinical features, diagnosis, and management of enterovirus 71. |
| Q41024528 | Co-infection of enterovirus 71 and Staphylococcus aureus in a 6-month-old male infant |
| Q37639803 | Comparison between Chinese Herbal Medicines and Conventional Therapy in the Treatment of Severe Hand, Foot, and Mouth Disease: A Randomized Controlled Trial. |
| Q33794054 | Derivation and Validation of a Mortality Risk Score for Severe Hand, Foot and Mouth Disease in China |
| Q37682898 | Development of enterovirus 71 vaccines. |
| Q42281389 | Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease |
| Q38245116 | Enteroviral encephalitis in children: clinical features, pathophysiology, and treatment advances |
| Q34362945 | Enterovirus 71 infection: An experience in Korea, 2009 |
| Q42588563 | Enterovirus 71 related severe hand, foot and mouth disease outbreaks in South-East Asia: current situation and ongoing challenges |
| Q60922605 | Enterovirus A71 Infection and Neurologic Disease, Madrid, Spain, 2016 |
| Q42154884 | GITRL as a genetic adjuvant enhances enterovirus 71 VP1 DNA vaccine immunogenicity. |
| Q36108024 | High risk factors for severe hand, foot and mouth disease: a multicenter retrospective survey in Anhui Province China, 2008-2009. |
| Q37333607 | Identification of 20 common human enterovirus serotypes by use of a reverse transcription-PCR-based reverse line blot hybridization assay |
| Q36553419 | Impact of Human Enterovirus 71 Genotypes in Meningoencephalitis in Iran |
| Q23005447 | Improving the efficacy of conventional therapy by adding andrographolide sulfonate in the treatment of severe hand, foot, and mouth disease: a randomized controlled trial |
| Q48429651 | In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis |
| Q33906139 | Machine Learning Algorithms for Risk Prediction of Severe Hand-Foot-Mouth Disease in Children |
| Q33769604 | Molecular identification and analysis of nonserotypeable human enteroviruses |
| Q92985600 | Nationwide Survey of Pediatric Inpatients With Hand, Foot, and Mouth Disease, Herpangina, and Associated Complications During an Epidemic Period in Japan: Estimated Number of Hospitalized Patients and Factors Associated With Severe Cases |
| Q30491567 | Neuro-Magnetic Resonance Imaging in Hand, Foot, and Mouth Disease: Finding in 412 Patients and Prognostic Features |
| Q36713602 | Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease |
| Q38009304 | Paroxysmal supraventricular tachycardia in an infant with hand, foot, and mouth disease |
| Q42254889 | Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine |
| Q42990560 | Relapse of hand foot and mouth disease: are we at more risk? |
| Q36536272 | Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. |
| Q38397888 | Risk factors of severe hand, foot and mouth disease: a meta-analysis |
| Q54968605 | Severity and burden of hand, foot and mouth disease in Asia: a modelling study. |
| Q40855930 | Status of research and development of vaccines for enterovirus 71. |
| Q89983634 | TREM-1 activation is a potential key regulator in driving severe pathogenesis of enterovirus A71 infection |
| Q37458096 | The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis. |
| Q64136886 | The Risk Factors of Acquiring Severe Hand, Foot, and Mouth Disease: A Meta-Analysis |
| Q34048432 | The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study |
| Q37886179 | The virology and developments toward control of human enterovirus 71. |
| Q38567118 | Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses |
| Q43951610 | Use of intravenous immunoglobulin compared with standard therapy is associated with improved clinical outcomes in children with acute encephalitis syndrome complicated by myocarditis. |
| Q37801742 | Virology, epidemiology, pathogenesis, and control of enterovirus 71. |
| Q90626060 | Willingness of parents to vaccinate their 6-60-month-old children with EV71 vaccines: a cross-sectional study in rural areas of northern Jiangsu Province |
| Q34844126 | Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia |
Search more.